Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons
Authors
Keywords
Mouse models, Neurons, Dopamine, Neostriatum, Parkinson disease, Dopaminergics, Mitochondria, Blood plasma
Journal
PLoS One
Volume 11, Issue 7, Pages e0159381
Publisher
Public Library of Science (PLoS)
Online
2016-07-29
DOI
10.1371/journal.pone.0159381
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ghrelin-AMPK Signaling Mediates the Neuroprotective Effects of Calorie Restriction in Parkinson's Disease
- (2016) J. A. Bayliss et al. JOURNAL OF NEUROSCIENCE
- Metformin induces PGC-1α expression and selectively affects hepatic PGC-1α functions
- (2014) Sanna-Mari Aatsinki et al. BRITISH JOURNAL OF PHARMACOLOGY
- Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy
- (2014) Teng Jiang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls
- (2014) C. A. Bannister et al. DIABETES OBESITY & METABOLISM
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice
- (2014) S.P. Patil et al. NEUROSCIENCE
- Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide
- (2014) Krzysztof Łabuzek et al. Pharmacological Reports
- The SIRT1 Activator SRT1720 Extends Lifespan and Improves Health of Mice Fed a Standard Diet
- (2014) Sarah J. Mitchell et al. Cell Reports
- Metformin-inclusive Therapy Reduces the Risk of Stroke in Patients with Diabetes: A 4-Year Follow-up Study
- (2013) Yuan-Yang Cheng et al. Journal of Stroke & Cerebrovascular Diseases
- mTOR is a key modulator of ageing and age-related disease
- (2013) Simon C. Johnson et al. NATURE
- The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro
- (2013) Marija Dulovic et al. NEUROBIOLOGY OF DISEASE
- Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
- (2013) H. A. Hirsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin improves healthspan and lifespan in mice
- (2013) Alejandro Martin-Montalvo et al. Nature Communications
- Ghrelin is neuroprotective in Parkinson’s disease: molecular mechanisms of metabolic neuroprotection
- (2013) Jacqueline A. Bayliss et al. Therapeutic Advances in Endocrinology and Metabolism
- SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
- (2012) Nathan L. Price et al. Cell Metabolism
- Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation
- (2012) Jing Wang et al. Cell Stem Cell
- AMP Kinase Activation Mitigates Dopaminergic Dysfunction and Mitochondrial Abnormalities in Drosophila Models of Parkinson's Disease
- (2012) C.-H. Ng et al. JOURNAL OF NEUROSCIENCE
- Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study
- (2012) Patrick Imfeld et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
- (2012) Mark L. Wahlqvist et al. PARKINSONISM & RELATED DISORDERS
- Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice
- (2012) Jiejie Li et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Association of PGC-1alphapolymorphisms with age of onset and risk of Parkinson's disease
- (2011) Joanne Clark et al. BMC Medical Genetics
- PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
- (2011) Joo-Ho Shin et al. CELL
- The cardioprotective effects of metformin
- (2011) Saloua El Messaoudi et al. CURRENT OPINION IN LIPIDOLOGY
- Mechanisms Underlying Metformin-Induced Secretion of Glucagon-Like Peptide-1 from the Intestinal L Cell
- (2011) Andrew J. Mulherin et al. ENDOCRINOLOGY
- The Role of Metformin in the Management of NAFLD
- (2011) Angela Mazza et al. Experimental Diabetes Research
- GPA protects the nigrostriatal dopamine system by enhancing mitochondrial function
- (2011) Tamas L. Horvath et al. NEUROBIOLOGY OF DISEASE
- AMP-activated protein kinase (AMPK) 1 2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise
- (2011) H. M. O'Neill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients
- (2010) Arpita Chakraborty et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice
- (2010) J. E. Ayala et al. Disease Models & Mechanisms
- Berberine suppresses neuroinflammatory responses through AMP-activated protein kinase activation in BV-2 microglia
- (2010) Dah-Yuu Lu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5
- (2010) Paul W Caton et al. JOURNAL OF ENDOCRINOLOGY
- Review: Metformin: Potential benefits and use in chronic kidney disease
- (2010) HELEN L PILMORE NEPHROLOGY
- Insulin resistance is associated with the pathology of Alzheimer disease: The Hisayama Study
- (2010) T. Matsuzaki et al. NEUROLOGY
- Metformin Induces a Dietary Restriction–Like State and the Oxidative Stress Response to Extend C. elegans Healthspan via AMPK, LKB1, and SKN-1
- (2010) Brian Onken et al. PLoS One
- Effects of Metformin in Experimental Stroke
- (2010) Jun Li et al. STROKE
- AMP-activated protein kinase is activated in Parkinson’s disease models mediated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- (2009) Jae-Sun Choi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Recent progress in the biology and physiology of sirtuins
- (2009) Toren Finkel et al. NATURE
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
- (2009) Carles Cantó et al. NATURE
- Diabetes preceding Parkinson's disease onset. A case–control study
- (2009) Marco D'Amelio et al. PARKINSONISM & RELATED DISORDERS
- GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
- (2009) Y. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
- (2008) J. A. Driver et al. DIABETES CARE
- Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats
- (2008) Feng Jin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- SirT1 Regulates Energy Metabolism and Response to Caloric Restriction in Mice
- (2008) Gino Boily et al. PLoS One
- Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease
- (2007) Göran Bertilsson et al. JOURNAL OF NEUROSCIENCE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now